Trial
NCT01736358
The Use of Intranasal Ketoralac for Pain Management (Sprix)
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Montefiore Medical Center
Collaborators
—
Condition
Postoperative Pain Management
Intervention
Intranasal Ketoralac
Why stopped
Interim analysis showed futility of primary endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-13